IL138916A0 - Quinolin-4-yl derivatives ii - Google Patents

Quinolin-4-yl derivatives ii

Info

Publication number: IL138916A0
Authority: IL; Israel
Prior art keywords: quinolin; derivatives
Prior art date: 1999-10-08

Application number

IL13891600A

Other languages

English (en)

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-08

Filing date

2000-10-05

Publication date

2001-11-25

2000-10-05 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2001-11-25 Publication of IL138916A0 publication Critical patent/IL138916A0/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

IL13891600A 1999-10-08 2000-10-05 Quinolin-4-yl derivatives ii IL138916A0 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP99120131		1999-10-08

Publications (1)

Publication Number	Publication Date
IL138916A0 true IL138916A0 (en)	2001-11-25

Family

ID=8239160

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL13891600A IL138916A0 (en)	1999-10-08	2000-10-05	Quinolin-4-yl derivatives ii

Country Status (26)

Country	Link
US (1)	US6339093B1 (xx)
EP (1)	EP1090917B1 (xx)
JP (1)	JP3385318B2 (xx)
KR (1)	KR100398562B1 (xx)
CN (1)	CN1162424C (xx)
AR (1)	AR032601A1 (xx)
AT (1)	ATE313538T1 (xx)
AU (1)	AU777881B2 (xx)
BR (1)	BR0004709A (xx)
CA (1)	CA2322309C (xx)
DE (1)	DE60024947T2 (xx)
DK (1)	DK1090917T3 (xx)
EG (1)	EG23872A (xx)
ES (1)	ES2254095T3 (xx)
HR (1)	HRP20000652A2 (xx)
HU (1)	HUP0003938A2 (xx)
ID (1)	ID27526A (xx)
IL (1)	IL138916A0 (xx)
MA (1)	MA26753A1 (xx)
MX (1)	MXPA00009771A (xx)
NO (1)	NO20005031L (xx)
NZ (1)	NZ507303A (xx)
PE (1)	PE20010660A1 (xx)
PL (1)	PL343057A1 (xx)
TR (1)	TR200002893A3 (xx)
ZA (1)	ZA200005447B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6339093B1 (en) *	1999-10-08	2002-01-15	Hoffmann-La Roche Inc.	Isoquinoline derivatives
US7375136B2 (en) *	2001-03-08	2008-05-20	Emory University	pH-dependent NMDA receptor antagonists
US6831087B2 (en) *	2001-11-09	2004-12-14	Hoffmann-La Roche Inc.	Pyridine substituted isoquinoline derivatives
US7005432B2 (en) *	2002-05-16	2006-02-28	Hoffman-La Roche Inc.	Substituted imidazol-pyridazine derivatives
US8110681B2 (en)	2006-03-17	2012-02-07	The United States Of America As Represented By The Secretary, Department Of Health And Human Services	Compounds for the treatment of spinal muscular atrophy and other uses
PT2167469E (pt) *	2007-06-18	2012-11-20	Richter Gedeon Nyrt	Derivados de sulfonil-quinoleína
US8420680B2 (en) *	2007-06-29	2013-04-16	Emory University	NMDA receptor antagonists for neuroprotection
CA2700841A1 (en) *	2007-09-27	2009-04-02	The United States Of America, As Represented By The Secretary, Departmen T Of Health And Human Services	Isoindoline compounds for the treatment of spinal muscular atrophy and other uses
US9938269B2 (en)	2011-06-30	2018-04-10	Abbvie Inc.	Inhibitor compounds of phosphodiesterase type 10A
JP6969800B2 (ja) *	2016-05-04	2021-11-24	ジェノシアンスファルマ	増殖性疾患の治療に使用される置換２，４−ジアミノ−キノリン誘導体
EP3558318B1 (en)	2016-12-22	2023-12-20	Novartis AG	Nmda receptor modulators and uses thereof
IL280474B2 (en)	2018-08-03	2023-09-01	Cadent Therapeutics Inc	Heteroaromatic nmda receptor modulators and their uses

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8409745D0 (en) *	1984-04-14	1984-05-23	Beecham Group Plc	Active compounds
US4560692A (en) *	1984-07-18	1985-12-24	Hoffmann-La Roche Inc.	4-Piperidino-2-phenylquinolines
GB8716972D0 (en) *	1987-07-17	1987-08-26	Pfizer Ltd	Treatment of cardiac arrhythmias
JPH0262875A (ja)	1988-05-23	1990-03-02	Wakunaga Pharmaceut Co Ltd	新規イソインドリン誘導体
US4992448A (en) *	1989-10-24	1991-02-12	Hoechst-Roussel Pharmaceuticals Inc.	Benzocycloalkylaminopyridinamines and related compounds as topical antiinflammatory agents for the treatment of skin disorders
US5304554A (en) *	1990-04-27	1994-04-19	Emory University	4-[(alkyl or dialkyl)amino]quinolines and their method of preparation
GB9203798D0 (en) *	1992-02-21	1992-04-08	Fujisawa Pharmaceutical Co	Quinolylbenzofuran derivatives,processes for preparation thereof and pharmaceutical composition comprising the same
GB9305644D0 (en) *	1993-03-18	1993-05-05	Merck Sharp & Dohme	Therapeutic agents
US5567718A (en) *	1994-08-11	1996-10-22	Hoechst Marion Roussel Inc.	2,3-dihydro-1h-isoindole derivatives and their use as serotonin reuptake inhibitors
ZA9610738B (en)	1995-12-22	1997-06-24	Warner Lambert Co	Subtype selective nmda receptor ligands and the use thereof
US6339093B1 (en) *	1999-10-08	2002-01-15	Hoffmann-La Roche Inc.	Isoquinoline derivatives

2000
- 2000-09-26 US US09/669,648 patent/US6339093B1/en not_active Expired - Fee Related
- 2000-09-29 CN CNB001290843A patent/CN1162424C/zh not_active Expired - Fee Related
- 2000-10-02 DK DK00121561T patent/DK1090917T3/da active
- 2000-10-02 EP EP00121561A patent/EP1090917B1/en not_active Expired - Lifetime
- 2000-10-02 ES ES00121561T patent/ES2254095T3/es not_active Expired - Lifetime
- 2000-10-02 DE DE60024947T patent/DE60024947T2/de not_active Expired - Lifetime
- 2000-10-02 AT AT00121561T patent/ATE313538T1/de not_active IP Right Cessation
- 2000-10-03 PE PE2000001045A patent/PE20010660A1/es not_active Application Discontinuation
- 2000-10-03 NZ NZ507303A patent/NZ507303A/xx unknown
- 2000-10-03 HR HR20000652A patent/HRP20000652A2/hr not_active Application Discontinuation
- 2000-10-04 CA CA002322309A patent/CA2322309C/en not_active Expired - Fee Related
- 2000-10-04 ID IDP20000858D patent/ID27526A/id unknown
- 2000-10-04 TR TR2000/02893A patent/TR200002893A3/tr unknown
- 2000-10-04 JP JP2000304354A patent/JP3385318B2/ja not_active Expired - Fee Related
- 2000-10-04 MA MA26080A patent/MA26753A1/fr unknown
- 2000-10-04 EG EG20001265A patent/EG23872A/xx active
- 2000-10-05 AR ARP000105238A patent/AR032601A1/es not_active Application Discontinuation
- 2000-10-05 IL IL13891600A patent/IL138916A0/xx unknown
- 2000-10-05 MX MXPA00009771A patent/MXPA00009771A/es active IP Right Grant
- 2000-10-05 ZA ZA200005447A patent/ZA200005447B/xx unknown
- 2000-10-06 BR BR0004709-0A patent/BR0004709A/pt not_active Application Discontinuation
- 2000-10-06 AU AU64100/00A patent/AU777881B2/en not_active Ceased
- 2000-10-06 HU HU0003938A patent/HUP0003938A2/hu unknown
- 2000-10-06 NO NO20005031A patent/NO20005031L/no not_active Application Discontinuation
- 2000-10-07 KR KR10-2000-0059049A patent/KR100398562B1/ko not_active IP Right Cessation
- 2000-10-09 PL PL00343057A patent/PL343057A1/xx not_active Application Discontinuation

Also Published As

Publication number	Publication date
CN1162424C (zh)	2004-08-18
EP1090917A1 (en)	2001-04-11
EP1090917B1 (en)	2005-12-21
ID27526A (id)	2001-04-12
CA2322309C (en)	2008-05-20
ATE313538T1 (de)	2006-01-15
TR200002893A2 (tr)	2001-04-20
AU777881B2 (en)	2004-11-04
ES2254095T3 (es)	2006-06-16
BR0004709A (pt)	2001-06-12
US6339093B1 (en)	2002-01-15
NO20005031D0 (no)	2000-10-06
CA2322309A1 (en)	2001-04-08
PL343057A1 (en)	2001-04-09
CN1304936A (zh)	2001-07-25
PE20010660A1 (es)	2001-06-26
EG23872A (en)	2007-11-27
HUP0003938A2 (hu)	2002-11-28
ZA200005447B (en)	2001-04-09
KR100398562B1 (ko)	2003-09-19
KR20010050915A (ko)	2001-06-25
DK1090917T3 (da)	2006-04-24
DE60024947T2 (de)	2006-09-21
NZ507303A (en)	2002-09-27
HRP20000652A2 (en)	2001-12-31
HU0003938D0 (en)	2000-12-28
AU6410000A (en)	2001-04-12
MA26753A1 (fr)	2004-12-20
DE60024947D1 (de)	2006-01-26
MXPA00009771A (es)	2002-10-23
NO20005031L (no)	2001-04-09
JP3385318B2 (ja)	2003-03-10
TR200002893A3 (tr)	2001-04-20
AR032601A1 (es)	2003-11-19
JP2001114777A (ja)	2001-04-24

Publication	Publication Date	Title
GB9904103D0 (en)	1999-04-14	Quinoline derivatives
EG23817A (en)	2007-09-19	4-Phenyl-pyridine derivatives
HUP0201535A2 (en)	2002-08-28	5-cyano-2-aminopyrimidine derivatives
IL148167A0 (en)	2002-09-12	Amino-triazolopyridine derivatives
GC0000183A (en)	2006-03-29	3-Phenyl-pyridine derivatives
IL145739A0 (en)	2002-07-25	13-methyl-erythromycin derivatives
GC0000338A (en)	2007-03-31	5-Phenyl-pyrimidine derivatives
IL148837A0 (en)	2002-09-12	Isoxazolecarboxamide derivatives
GC0000191A (en)	2006-03-29	4-Phenyl-pyrimidine derivatives
IL138916A0 (en)	2001-11-25	Quinolin-4-yl derivatives ii
HU0003861D0 (en)	2000-12-28	Quinolin-4-yl derivatives
GB9925880D0 (en)	1999-12-29	B-Carboline derivatives
IL147636A0 (en)	2002-08-14	3-amino-2-benzyl-1-phenyl-propane derivatives
IL150132A0 (en)	2002-12-01	Cyclopenteneone derivatives
GC0000256A (en)	2006-11-01	Ethanesulfonyl-piperidine derivatives
IL145949A0 (en)	2002-07-25	1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
PL351407A1 (en)	2003-04-22	Thio-oxindole derivatives
GB9904102D0 (en)	1999-04-14	Quinoline derivatives
GB9904104D0 (en)	1999-04-14	Quinoline derivatives
GB9904105D0 (en)	1999-04-14	Quinoline derivatives
GB9907134D0 (en)	1999-05-19	Antimor napthylcombretastatin derivatives
IL146282A0 (en)	2002-07-25	Thio-oxindole derivatives
HK1043987A1 (zh)	2002-10-04	硫-羥吲衍生物